Skip to main content

Security report for lexogen.com

Lexogen GmbH · Healthcare · Austria

High risk. 7 critical or high findings in GDPR outside view, SSL/TLS and 1 other check.

Security score

35/100

Risk levelHigh

0–100, higher is better. How it is calculated

Lexogen GmbH is a specialized biotechnology company based in Vienna, Austria, focused on next generation sequencing (NGS) and transcriptomics solutions. The company offers a comprehensive portfolio of RNA analysis products, including RNA-Seq sample preparation kits, RNA spike-in controls, and bioinformatics data analysis services. Their target audience includes researchers, pharmaceutical companies, and academic institutions seeking innovative RNA sequencing and analysis solutions. Lexogen positions itself as a niche leader with ISO 9001 and ISO 13485 certifications, underscoring its commitment to quality and regulatory compliance. Technically, the website is built on WordPress using Elementor and WooCommerce, hosted on Cloudpit infrastructure. The site integrates modern web technologies such as Google Tag Manager and reCAPTCHA for analytics and security. While the site is mobile optimized and SEO friendly with good content quality and navigation, performance metrics are unavailable. The absence of a valid SSL/TLS certificate is a critical security gap, exposing users to insecure HTTP connections. From a security perspective, the site lacks HTTPS, HSTS, and other essential security headers, resulting in a low security posture score. No explicit security or incident response policies are published. Privacy compliance is strong, with a comprehensive privacy policy and cookie consent mechanism aligned with GDPR requirements. Contact information is detailed and trustworthy, including multiple phone numbers, emails, and physical addresses in Austria and the USA. Overall, Lexogen's website demonstrates strong business credibility and content quality but suffers from a critical security deficiency due to missing HTTPS. Strategic improvements in SSL implementation and security headers are essential to enhance user trust and data protection. The company’s digital maturity is moderate, with opportunities to improve technical infrastructure and security practices to better support its specialized biotech market presence.

Scanned

NIS2 and GDPR posture

GDPR outside view
18/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching lexogen.com

This scan found 19 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
15
Email security
50
DNS health
85
Network security
40
GDPR outside view
18
Average
35

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Lexogen operates in the healthcare biotechnology sector, specializing in RNA sequencing and transcriptomics. Their business model is primarily B2B, selling products and services to research institutions and biotech firms. The company leverages a strong partnership ecosystem, including distributors and technical support portals. Their market positioning as RNA experts is reinforced by ISO certifications and extensive product offerings. Growth indicators include frequent blog updates, webinars, and a comprehensive RNA expertise hub. The company maintains a professional online presence with clear branding and multiple social media channels. Revenue streams likely include product sales, custom bioinformatics services, and sequencing services. Lexogen’s operations are consistent with a medium-sized enterprise founded in 2015, with no parent or subsidiary companies identified.

Security posture

The website’s security maturity is low due to the absence of HTTPS and related SSL/TLS configurations. This exposes visitors to potential data interception and undermines trust. No advanced security headers or mechanisms such as HSTS, OCSP stapling, or session resumption are implemented. The site uses Google reCAPTCHA to protect forms, which is a positive security control. No vulnerabilities such as Heartbleed or POODLE are detected, but the lack of encryption is a critical issue. There is no visible incident response or vulnerability disclosure policy, which limits transparency and preparedness. Privacy compliance is well addressed with GDPR-aligned policies and cookie consent. Overall, the security posture requires urgent enhancement to meet industry best practices and regulatory expectations.

Recommendations

  1. Implement a valid SSL/TLS certificate to enable HTTPS across the entire website immediately.
  2. Configure HTTP Strict Transport Security (HSTS) with includeSubDomains and preload directives.
  3. Add essential security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
  4. Publish a clear security policy and vulnerability disclosure program to improve transparency and incident response readiness.
  5. Regularly audit and update all third-party plugins and scripts to mitigate potential vulnerabilities.

Contact details published on the site

Addresses
Legal name
Lexogen GmbH
VAT number
ATU63622048
Registration number
FN 297318 h
Technical notes

Notes

The website is built on a modern WordPress CMS platform with Elementor page builder and WooCommerce for e-commerce functionality. It uses nginx as the web server and is hosted on Cloudpit infrastructure. The site integrates Google Fonts, Google Tag Manager, and Google reCAPTCHA for analytics and security. Despite modern technologies, the site lacks performance data, making it difficult to assess loading speed. Mobile optimization is good, and SEO practices are well implemented with proper meta tags and structured data (JSON-LD). The absence of HTTPS is a significant technical risk. The site uses multiple JavaScript libraries including jQuery and various Elementor and WooCommerce scripts. Overall, the technical infrastructure is solid but requires security upgrades and performance monitoring.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 32/100High29 findingsView report
Reviews of this site

Share your experience with lexogen.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review lexogen.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.